Erythromycin for prokinesis: imprudent prescribing?

dc.contributor.author	Dall'Antonia, M
dc.contributor.author	Wilks, M
dc.contributor.author	Coen, PG
dc.contributor.author	Bragman, S
dc.contributor.author	Millar, MR
dc.date.accessioned	2017-12-06T11:23:19Z
dc.date.available	2017-12-06T11:23:19Z
dc.date.issued	2005-12-19
dc.date.submitted	2017-10-12T12:17:07.881Z
dc.identifier.citation	Dall'Antonia, Martino et al. Critical Care 10.1 (2006): 112. Web. 6 Dec. 2017.	en_US
dc.identifier.issn	1466-609X
dc.identifier.other	112
dc.identifier.other	112
dc.identifier.uri	http://qmro.qmul.ac.uk/xmlui/handle/123456789/29111
dc.format.extent	? - ?
dc.language.iso	en	en_US
dc.publisher	BioMed Central	en_US
dc.relation.ispartof	CRIT CARE
dc.relation.isreplacedby	123456789/54424
dc.relation.isreplacedby	https://qmro.qmul.ac.uk/handle/123456789/54424
dc.subject	CLOSTRIDIUM-DIFFICILE	en_US
dc.subject	RESISTANCE	en_US
dc.subject	SUSCEPTIBILITY	en_US
dc.title	Erythromycin for prokinesis: imprudent prescribing?	en_US
dc.type	Article	en_US
dc.rights.holder	© BioMed Central Ltd 2005
dc.identifier.doi	10.1186/cc3956
pubs.issue	1
pubs.volume	10